Gain Therapeutics (NASDAQ:GANX) just reported results for the second quarter of 2024.
- Gain Therapeutics reported earnings per share of -42 cents. This was below the analyst estimate for EPS of -20 cents.
- The company did not report any revenue for the quarter.